172 related articles for article (PubMed ID: 19946338)
21. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
22. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.
Zhang Y; Woodford N; Xia X; Hamburger AW
Nucleic Acids Res; 2003 Apr; 31(8):2168-77. PubMed ID: 12682367
[TBL] [Abstract][Full Text] [Related]
23. Shared and distinct roles of Esc2 and Mms21 in suppressing genome rearrangements and regulating intracellular sumoylation.
Suhandynata RT; Gao YQ; Zhou AL; Yang Y; Wang PC; Zhou H
PLoS One; 2021; 16(2):e0247132. PubMed ID: 33600463
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
[TBL] [Abstract][Full Text] [Related]
25. Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells.
Ko HR; Chang YS; Park WS; Ahn JY
Int J Cancer; 2016 Sep; 139(6):1202-8. PubMed ID: 27130196
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
[TBL] [Abstract][Full Text] [Related]
27. Muscle RING-finger protein-1 (MuRF1) functions and cellular localization are regulated by SUMO1 post-translational modification.
Heras G; Namuduri AV; Traini L; Shevchenko G; Falk A; Bergström Lind S; Jia M; Tian G; Gastaldello S
J Mol Cell Biol; 2019 May; 11(5):356-370. PubMed ID: 29868881
[TBL] [Abstract][Full Text] [Related]
28. Structural insights into the transcriptional and translational roles of Ebp1.
Monie TP; Perrin AJ; Birtley JR; Sweeney TR; Karakasiliotis I; Chaudhry Y; Roberts LO; Matthews S; Goodfellow IG; Curry S
EMBO J; 2007 Sep; 26(17):3936-44. PubMed ID: 17690690
[TBL] [Abstract][Full Text] [Related]
29. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.
Akinmade D; Talukder AH; Zhang Y; Luo WM; Kumar R; Hamburger AW
Br J Cancer; 2008 Mar; 98(6):1132-40. PubMed ID: 18283314
[TBL] [Abstract][Full Text] [Related]
31. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
[TBL] [Abstract][Full Text] [Related]
32. Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation.
Bao Y; Suvesh M; Li X; Bai X; Li H; Li X; Xu D; Liu L
Mol Carcinog; 2021 Apr; 60(4):252-264. PubMed ID: 33634940
[TBL] [Abstract][Full Text] [Related]
33. Sumoylation of CoREST modulates its function as a transcriptional repressor.
Muraoka A; Maeda A; Nakahara N; Yokota M; Nishida T; Maruyama T; Ohshima T
Biochem Biophys Res Commun; 2008 Dec; 377(4):1031-5. PubMed ID: 18854179
[TBL] [Abstract][Full Text] [Related]
34. EBP1 regulates Suv39H1 stability via the ubiquitin-proteasome system in neural development.
Kim BS; Ko HR; Hwang I; Cho SW; Ahn JY
BMB Rep; 2021 Aug; 54(8):413-418. PubMed ID: 33691908
[TBL] [Abstract][Full Text] [Related]
35. ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.
Ghosh A; Awasthi S; Hamburger AW
Oncol Rep; 2013 Mar; 29(3):1161-6. PubMed ID: 23242156
[TBL] [Abstract][Full Text] [Related]
36. TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.
Pungaliya P; Kulkarni D; Park HJ; Marshall H; Zheng H; Lackland H; Saleem A; Rubin EH
J Proteome Res; 2007 Oct; 6(10):3918-23. PubMed ID: 17803295
[TBL] [Abstract][Full Text] [Related]
37. E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2.
Anandapadamanaban M; Kyriakidis NC; Csizmók V; Wallenhammar A; Espinosa AC; Ahlner A; Round AR; Trewhella J; Moche M; Wahren-Herlenius M; Sunnerhagen M
J Biol Chem; 2019 Jul; 294(30):11404-11419. PubMed ID: 31160341
[TBL] [Abstract][Full Text] [Related]
38. Activation of the Slx5-Slx8 ubiquitin ligase by poly-small ubiquitin-like modifier conjugates.
Mullen JR; Brill SJ
J Biol Chem; 2008 Jul; 283(29):19912-21. PubMed ID: 18499666
[TBL] [Abstract][Full Text] [Related]
39. ERBB3-Binding Protein 1 (EBP1) Is a Novel Developmental Pluripotency-Associated-4 (DPPA4) Cofactor in Human Pluripotent Cells.
Somanath P; Bush KM; Knoepfler PS
Stem Cells; 2018 May; 36(5):671-682. PubMed ID: 29327467
[TBL] [Abstract][Full Text] [Related]
40. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
